# Evoke Pharma Inc. (EVOK)

Source: https://www.quantisnow.com/company/EVOK
Generated: 2026-11-13T01:35:31.859Z

- Ticker: EVOK
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2013
- Website: evokepharma.com

## About

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase III clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.

## Latest EVOK news and filings

- 2025-12-30 17:12 UTC [SEC Form 15-12G filed by Evoke Pharma Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-evoke-pharma-inc-6329624)
- 2025-12-19 21:15 UTC [SEC Form 4] [Large owner Nantahala Capital Management, Llc disposed of $1,629,683 worth of shares (148,153 units at $11.00) (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-nantahala-capital-management-llc-disposed-of-1629683-worth-6323805)
- 2025-12-19 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Evoke Pharma Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-evoke-pharma-inc-6322981)
- 2025-12-19 05:16 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Evoke Pharma Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-evoke-pharma-inc-6322978)
- 2025-12-19 05:16 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Evoke Pharma Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-evoke-pharma-inc-6322976)
- 2025-12-19 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Evoke Pharma Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-evoke-pharma-inc-6322972)
- 2025-12-19 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Evoke Pharma Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-evoke-pharma-inc-6322971)
- 2025-12-19 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Evoke Pharma Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-evoke-pharma-inc-6322967)
- 2025-12-17 21:08 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Evoke Pharma Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-evoke-pharma-inc-6319914)
- 2025-12-17 21:07 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Evoke Pharma Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-evoke-pharma-inc-6319896)
- 2025-12-17 21:06 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Evoke Pharma Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-evoke-pharma-inc-6319889)
- 2025-12-17 21:06 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Evoke Pharma Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-evoke-pharma-inc-6319866)
- 2025-12-17 21:05 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Evoke Pharma Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-evoke-pharma-inc-6319844)
- 2025-12-17 21:04 UTC [SEC Form POS AM filed by Evoke Pharma Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-evoke-pharma-inc-6319806)
- 2025-12-17 21:03 UTC [SEC Form POS AM filed by Evoke Pharma Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-evoke-pharma-inc-6319801)
- 2025-12-17 21:02 UTC [SEC Form POS AM filed by Evoke Pharma Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-evoke-pharma-inc-6319795)
- 2025-12-17 21:01 UTC [SEC Form POS AM filed by Evoke Pharma Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-evoke-pharma-inc-6319790)
- 2025-12-17 21:01 UTC [SEC Form POS AM filed by Evoke Pharma Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-evoke-pharma-inc-6319780)
- 2025-12-17 21:00 UTC [SEC Form 4] [SEC Form 4 filed by Director Pyszczymuka Greg](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-pyszczymuka-greg-6319763)
- 2025-12-17 21:00 UTC [SEC Form 4] [Chief Medical Officer Carlson Marilyn R. closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-medical-officer-carlson-marilyn-r-closing-all-direct-ownership-6319762)
- 2025-12-17 21:00 UTC [SEC Form 4] [SEC Form 4 filed by Director Smeal Benjamin C.](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-smeal-benjamin-c-6319761)
- 2025-12-17 21:00 UTC [SEC Form 4] [SEC Form 4 filed by Director Garner Cam L](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-garner-cam-l-6319760)
- 2025-12-17 21:00 UTC [SEC Form POS AM filed by Evoke Pharma Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-evoke-pharma-inc-6319759)
- 2025-12-17 21:00 UTC [SEC Form 4] [SEC Form 4 filed by Director Reed Vickie S](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-reed-vickie-s-6319758)
- 2025-12-17 21:00 UTC [SEC Form 4] [Director Brady Todd C closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-brady-todd-c-closing-all-direct-ownership-in-the-6319757)
- 2025-12-17 21:00 UTC [SEC Form 4] [SEC Form 4 filed by Director Widder Kenneth J](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-widder-kenneth-j-6319756)
- 2025-12-17 21:00 UTC [SEC Form 4] [Chief Executive Officer D'Onofrio Matthew J closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-donofrio-matthew-j-closing-all-direct-ownership-6319755)
- 2025-12-17 21:00 UTC [SEC Form 4] [Chief Financial Officer Kowieski Mark closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-kowieski-mark-closing-all-direct-ownership-in-6319754)
- 2025-12-17 21:00 UTC [SEC Form 4] [Director Hill Malcolm R closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-hill-malcolm-r-closing-all-direct-ownership-in-the-6319753)
- 2025-12-17 15:50 UTC [Evoke Pharma and QOL Medical Announce Expiration of Tender Offer](https://www.quantisnow.com/insight/evoke-pharma-and-qol-medical-announce-expiration-of-tender-offer-6319497)
- 2025-12-17 14:38 UTC [SEC Form 25-NSE filed by Evoke Pharma Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-evoke-pharma-inc-6319438)
- 2025-12-17 14:22 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by Evoke Pharma Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-evoke-pharma-inc-6319382)
- 2025-12-17 14:08 UTC [SEC Form 8-K] [Evoke Pharma Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update](https://www.quantisnow.com/insight/evoke-pharma-inc-filed-sec-form-8-k-completion-of-acquisition-6319334)
- 2025-12-05 21:03 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Evoke Pharma Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-evoke-pharma-inc-6304936)
- 2025-11-17 11:49 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9 filed by Evoke Pharma Inc.](https://www.quantisnow.com/insight/sec-form-sc-14d9-filed-by-evoke-pharma-inc-6281960)
- 2025-11-13 12:17 UTC [SEC Form SC14D9C filed by Evoke Pharma Inc.](https://www.quantisnow.com/insight/sec-form-sc14d9c-filed-by-evoke-pharma-inc-6276076)
- 2025-11-13 12:05 UTC [SEC Form 8-K] [Evoke Pharma Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/evoke-pharma-inc-filed-sec-form-8-k-results-of-operations-6276052)
- 2025-11-13 12:00 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Evoke Pharma Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-evoke-pharma-inc-6276035)
- 2025-11-13 12:00 UTC [Evoke Pharma Reports Third Quarter 2025 Financial Results and Provides Business Update](https://www.quantisnow.com/insight/evoke-pharma-reports-third-quarter-2025-financial-results-and-provides-6275984)
- 2025-11-07 21:58 UTC [SEC Form 4] [Large owner Klein Roger M. sold $95,885 worth of shares (9,000 units at $10.65) (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-klein-roger-m-sold-95885-worth-of-shares-6268714)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/EVOK
- Earnings history: https://www.quantisnow.com/earnings/EVOK
- Dividend history: https://www.quantisnow.com/dividends/EVOK
- Insider transactions: https://www.quantisnow.com/insiders/EVOK
- Options chain: https://www.quantisnow.com/options/EVOK
- SEC 8-K filings only: https://www.quantisnow.com/company/EVOK/8-k
- RSS and alerts for EVOK: https://www.quantisnow.com/docs/rss-feeds.md